> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Encourages Patient-Focused Drug Development Meetings
- URL: https://www.fdaweb.com/fda-encourages-patient-focused-drug-development-meetings/
- Published: 2016-01-04T12:00:00.000Z
- Updated: 2026-09-15T02:23:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134308

*Federal Register* Notice: FDA is announcing the opportunity for externally-led patient-focused drug development meetings. FDA recognizes that there are many more disease areas than can be addressed in the planned FDA meetings under PDUFA V and it welcomes patient organizations to identify and organize patient-focused collaborations to generate public input on other disease areas, using the process established through Patient-Focused Drug Development as a model. The agency recommends that patient organizations who are interested in conducting an externally-led PFDD meeting initially engage with FDA by submitting a letter of intent to patientfocused@fda.hhs.gov. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2015-12-28/pdf/2015-32476.pdf?ref=fdaweb.com)